Showing results (91-100 of 299) with videos related to
Sort By:
Pageof 30
JTO Clinical and Research Reports|May 23, 2022
Autoimmune Disease in Patients With Advanced Thymic Epithelial TumorsSurbhi Singhal, Jessica Hellyer, Madhu M Ouseph, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
Osteoblastic bone flare on F18-FDG PET in non-small cell lung cancer (NSCLC) patients receiving bevacizumab in addition to standard chemotherapyYelena Krupitskaya, Hedieh K Eslamy, Dorothy D Nguyen, et al.Neuro-Oncology Advances|December 3, 2021
Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapiesNathaniel J Myall, Helena Yu, Scott G Soltys, et al.Journal of Neuro-Oncology|January 8, 2021
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastasesMichael Zhang, Adrian J Rodrigues, Erqi L Pollom, et al.Nature Reviews. Clinical Oncology|December 24, 2014
Developing biomarker-specific end points in lung cancer clinical trialsJoel W Neal, Justin F Gainor, Alice T ShawLung Cancer (Amsterdam, Netherlands)|September 16, 2025
Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancerFangdi Sun, Mandeep K Banwait, Surbhi Singhal, et al.Nature Medicine|April 8, 2014
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageAaron M Newman, Scott V Bratman, Jacqueline To, et al.World Journal of Clinical Oncology|October 11, 2014
Review of the current targeted therapies for non-small-cell lung cancerKim-Son H Nguyen, Joel W Neal, Heather WakeleeCurrent Treatment Options in Oncology|September 5, 2015
Management of Dermatologic Complications of Lung Cancer TherapiesSilvina B Pugliese, Joel W Neal, Bernice Y KwongNature Reviews. Cancer|May 3, 2023
Dissecting metastasis using preclinical models and methodsJess D Hebert, Joel W Neal, Monte M WinslowPageof 30